SK
Sanjay Kumar Sinha
About Sanjay Kumar Sinha
Data last updated:
Sanjay Kumar Sinha is a Managing Director at Hauz Pharma Private Limited (since 2009) and Director at Sanovia Biotech Private Limited (since 2016). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹32.14 Cr; the largest is Hauz Pharma Private Limited at ₹30.46 Cr (FY 2024). Earlier, Sanjay Kumar Sinha was a Director at Ultra Biolabs Private Limited (2011–2015) and Director at Zentis Drugs Private Limited (2010–2011) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 29 May 2009 | 2009 | ₹30.46 Cr (FY 2024) | Active | |
| Director | 10 Oct 2016 | 2016 | ₹1.68 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Apr 2011 | 2011 | ₹10.26 Cr (FY 2024) | Active | |
| Director | 29 Mar 2010 | 2010 | ₹1.20 Cr (FY 2025) | Active | |
| Director | 04 Mar 2015 | 2011 | ₹3.06 Cr (FY 2024) | Active | |
| Director | 28 Jan 2014 | 2014 | ₹2.51 Cr (FY 2025) | Active | |
| Director | 01 Feb 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Kumar Sinha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vikas Sharma | 02307088 | Hauz Pharma Private Limited , Sanovia Biotech Private Limited | Director |
| Manoj Nigam | 05157456 | Sanovia Biotech Private Limited | Director |
| Vandna Thakur | 09084998 | Sanovia Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kumar Sinha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kumar Sinha
Sanjay Kumar Sinha currently holds 2 directorships: Hauz Pharma Private Limited (Managing Director, since 29 May 2009, revenue ₹30.46 Cr (FY 2024)); Sanovia Biotech Private Limited (Director, since 10 Oct 2016, revenue ₹1.68 Cr (FY 2025)).
Sanjay Kumar Sinha was first appointed on 29 May 2009 as Managing Director at Hauz Pharma Private Limited. The most recent appointment on record is 10 Oct 2016 at Sanovia Biotech Private Limited.
The 2 current companies of Sanjay Kumar Sinha that report revenue have a combined latest revenue of ₹32.14 Cr: Hauz Pharma Private Limited ₹30.46 Cr (FY 2024); Sanovia Biotech Private Limited ₹1.68 Cr (FY 2025).
Sanjay Kumar Sinha held 5 earlier board appointments: Ultra Biolabs Private Limited (Director, 20 Apr 2011 to 01 Dec 2015); Zentis Drugs Private Limited (Director, 29 Mar 2010 to 04 Jun 2011); Alisier Drugs Private Limited (Director, 04 Mar 2015 to 02 Apr 2016); Eviza Biotech Private Limited (Director, 28 Jan 2014 to 30 Jul 2014); Ultra Health Care Private Limited (Director, from 01 Feb 2012).
The current boards of Sanjay Kumar Sinha's companies include Vikas Sharma (Hauz Pharma Private Limited), Manoj Nigam (Sanovia Biotech Private Limited), Vandna Thakur (Sanovia Biotech Private Limited).